Effect of CYP3A5 Genotype on Renal Allograft Recipients Treated With Tacrolimus

CYP3A5 influenced the blood concentrations of tacrolimus. Our study suggested to choose the initial dosage according to the CYP3A5 genotype to obtain a better outcome and reduce the incidences of acute rejection episodes and nephrotoxicity.